June 23, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options. Women experienced greater weight loss and the same symptom benefits compared with …Read More
Previous Article‘A hearty debate’ concludes plant-based meat alternatives are healthier for your heart than meat-Click Here